Evidence map›Paper›PMID 15472302›Full record

ArticleJournal of clinical microbiology2004

Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens.

Claudia Schabereiter-Gurtner, Alexander M Hirschl, Brigitte Dragosics, Peter Hufnagl, Sonja Puz, Zsuzsanna Kovách, Manfred Rotter, Athanasios Makristathis

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 193 citations in OpenAlex.

  1. BioMed research international · 2017
    Trial
  2. Antibiotic Resistance ofJournal of Korean medical science · 2024
    Review
  3. Article
  4. Biofilm ofAntibiotics (Basel, Switzerland) · 2023
    Review
  5. Antibiotic Resistance, Susceptibility Testing and Stewardship inInternational journal of molecular sciences · 2023
    Review
  6. The State of the Art of Molecular Fecal Investigations forInternational journal of molecular sciences · 2023
    Review
  7. Management ofJGH open : an open access journal of gastroenterology and hepatology · 2023
    Review
  8. Article
  9. Cost-effectiveness of screening with polymerase chain reaction forJournal of gastrointestinal oncology · 2022
    Article
  10. Review
  11. Article
  12. New Strategy for the Detection and Treatment ofJournal of clinical medicine · 2022
    Article
  13. Rapid Detection of Quinolone Resistance Mutations inPathogens (Basel, Switzerland) · 2022
    Article
  14. Tumor tissueDental research journal · 2022
    Article
  15. Review
  16. Article
  17. Polymerase chain reaction-based tests for detectingWorld journal of clinical cases · 2021
    Article
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Claudia Schabereiter-GurtnerDepartment of Clinical Microbiology, Institute of Hygiene and Medical Microbiology, Medical University of Vienna, Vienna, Austria.
Alexander M Hirschl
Brigitte Dragosics
Peter Hufnagl
Sonja Puz
Zsuzsanna Kovách
Manfred Rotter
Athanasios Makristathis
Institute of Medical Microbiology and Hygiene · DEMedical University of Vienna · ATRoche (Austria) · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A biprobe real-time PCR protocol, followed by hybridization melting point analysis, to detect point mutations in the 23S rRNA gene of Helicobacter pylori associated with clarithromycin resistance was established and evaluated in a clinical study. Of 92 patients who underwent endoscopy, 45 were found to be H. pylori infected and invariably were also culture positive. Of the 45 isolates, 11 were shown to be resistant to clarithromycin by E-test. With respect to the detection of H. pylori infection, PCR showed sensitivities of 100% in biopsies and 98% in stool specimens and a specificity of 98% in both biopsy and stool samples. All clarithromycin-sensitive cases were identified as such by PCR in both biopsy and stool samples. Of the cases with a resistant strain, eight were identified as such in stool DNA and nine were identified in biopsy DNA. Failure of PCR to detect the resistant genotype in the biopsy DNA, stool DNA, or both (one case) was associated with mixed populations. In these cases, patients had not been treated for H. pylori infection before, and the sensitive population showed to be present in considerably higher numbers than the resistant population. In five of six cases in which infection with a resistant genotype only was identified by PCR, the patients had received clarithromycin-based eradication therapy in the past. Thus, the assay presented provides a highly accurate noninvasive method to detect H. pylori infection in stool and at the same time allows for culture-independent clarithromycin susceptibility testing.

Indexed as

Drug Resistance, BacterialAdultAgedAged, 80 and overAnti-Bacterial AgentsBiopsyClarithromycinDNA, RibosomalFecesFemaleHelicobacter InfectionsHelicobacter pyloriHumansMaleMicrobial Sensitivity TestsMiddle AgedAnti-Bacterial AgentsClarithromycinDNA, RibosomalRNA, Ribosomal, 23S

Identifiers

PMID15472302
PMCPMC522301
OpenAlexW2134026501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.